Apr 02, 2020
Medicinal Genomics to Donate a Portion of CannMed Tickets Sales to COVID-19 Response
Apr 02, 2020
Dr. Bart Rademaker Offers Free Classes On Stem Cell Therapy And The Coronavirus
Apr 01, 2020
bestmarijuanaguide.com Announces Launch of Cannabis Directory and Reviews on April 1st, 2020
Mar 30, 2020
Inova Schar Cancer Institute Treats First Patient using Proton Therapy in Northern Virginia
Mar 30, 2020
SHL Medical acquires Weibel CDS
Mar 24, 2020
In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules , 2020-2030
Mar 20, 2020
Dental Care Habits of Americans Revealed in Honor of World Oral Health Day
Mar 19, 2020
Controlled Release Drug Delivery Market Size Worth $69.8 Billion by 2027: Grand View Research, Inc.
Mar 19, 2020
Planet 13 Offering Expanded Online Ordering and Delivery Services
Mar 19, 2020
PolarisQB and Fujitsu announce pioneering drug discovery platform to speed up the process of bringing new drugs to market
Mar 17, 2020
Alabama's Only Proton Therapy Center Treats First Patient with Varian ProBeam
Mar 17, 2020
Hemp-based products of Panaxia US and partner Ultra Health receive distribution and manufacturing license: Having passed the New Mexico NMED audit, Panaxia US received a first-of-its-kind license to manufacture and distribute products throughout the US
Mar 16, 2020
Global proton therapy market is expected to grow with a CAGR of 13.5% over the forecast period from 2019-2025
Mar 12, 2020
Cardiovascular Drug Delivery Market Insights, 2018-2028 Featuring Profiles of 82 Companies and 80 Collaborations
Mar 12, 2020
100% THC-Free Hemp & CBD Oil Company's 2020 Launch
Mar 11, 2020
Results from a Preliminary Hair Regrowth Case Study Using Vero Naturals CBD Beat Propecia® and Rivals Rogaine®
Mar 11, 2020
Vanderbilt Vaccine Center Acquires Octet HTX System to Speed Antibody Screening
Mar 09, 2020
Innovative Industrial Properties Acquires Illinois Property and Expands Real Estate Partnership with Green Thumb Industries (GTI)
Mar 09, 2020
Cannabis Delivery SaaS, Grow Cart, Wins Best of What's New Award
Mar 06, 2020
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft Survival of 89% After Imlifdase Treatment and Transplantation